Victor Cervera-Carrascon successfully defended his PhD on 19th February 2021 with thesis titled “Enabling PD-1 Axis Inhibitors Against Solid Tumours With Engineered Adenoviruses Armed With TNFa and IL-2”.
Congratulations, Dr. Cervera-Carrascon!
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 643130.